Showing results (911-920 of 1,334) with videos related to
Sort By:
Pageof 134
Bone Marrow Transplantation|April 5, 2016
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myelomaM Martino, R M Lemoli, C Girmenia, et al.Cancer Immunology Research|November 29, 2017
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma ModelSarah A Richman, Selene Nunez-Cruz, Babak Moghimi, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 23, 2021
Enhancing CAR T function with the engineered secretion of C. perfringens neuraminidaseJoseph S Durgin, Radhika Thokala, Lexus Johnson, et al.Obesity Surgery|May 27, 2019
Esophagogastric Neoplasms Following Bariatric Surgery: an Updated Systematic ReviewMario Musella, Giovanna Berardi, Alessio Bocchetti, et al.La Radiologia Medica|February 5, 2015
Crohn's disease of the small bowel: evaluation of ileal inflammation by diffusion-weighted MR imaging and correlation with the Harvey-Bradshaw indexPietro Valerio Foti, Renato Farina, Maria Coronella, et al.International Journal of Surgery (London, England)|May 27, 2014
Clinical outcome in differentiated thyroid carcinoma and microcarcinomaRoberta Lupoli, Marianna Cacciapuoti, Anna Tortora, et al.Frontiers in Psychiatry|May 3, 2021
An Exploratory Study of Emotional Dysregulation Dimensions in Youth With Attention Deficit Hyperactivity Disorder and/or Bipolar Spectrum DisordersGabriele Masi, Gianluca Sesso, Chiara Pfanner, et al.Diagnostics (Basel, Switzerland)|April 30, 2021
Diagnosis and Management of Rectal Neuroendocrine Tumors (NETs)Francesco Maione, Alessia Chini, Marco Milone, et al.Annals of Hematology|March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter studySalvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.Annals of Hematology|July 31, 2015
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agentsA Romano, N L Parrinello, M L Consoli, et al.Pageof 134